Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 10  •  04:00PM ET
23.43
Dollar change
-0.53
Percentage change
-2.21
%
Index
RUT
P/E
27.92
EPS (ttm)
0.84
Insider Own
4.63%
Shs Outstand
22.44M
Perf Week
-4.76%
Market Cap
533.04M
Forward P/E
16.12
EPS next Y
1.45
Insider Trans
-4.99%
Shs Float
21.70M
Perf Month
-15.90%
Enterprise Value
465.55M
PEG
-
EPS next Q
-0.12
Inst Own
97.11%
Perf Quarter
-23.76%
Income
19.09M
P/S
1.62
EPS this Y
39.33%
Inst Trans
0.31%
Perf Half Y
57.25%
Sales
329.52M
P/B
2.40
EPS next Y
27.21%
ROA
6.55%
Perf YTD
-19.21%
Book/sh
9.76
P/C
6.39
EPS next 5Y
-
ROE
8.77%
52W High
37.77 -37.97%
Perf Year
74.85%
Cash/sh
3.67
P/FCF
13.18
EPS past 3/5Y
- -
ROIC
8.24%
52W Low
8.61 172.13%
Perf 3Y
30.09%
Dividend Est.
-
EV/EBITDA
12.96
Sales past 3/5Y
10.12% 11.98%
Gross Margin
75.17%
Volatility
3.73% 3.89%
Perf 5Y
-56.61%
Dividend TTM
-
EV/Sales
1.41
EPS Y/Y TTM
21.28%
Oper. Margin
8.89%
ATR (14)
1.10
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
3.69
Sales Y/Y TTM
12.47%
Profit Margin
5.79%
RSI (14)
26.10
Dividend Gr. 3/5Y
- -
Current Ratio
4.03
EPS Q/Q
16.25%
SMA20
-9.54%
Beta
0.95
Payout
0.00%
Debt/Eq
0.07
Sales Q/Q
21.04%
SMA50
-14.79%
Rel Volume
0.56
Prev Close
23.96
Employees
1086
LT Debt/Eq
0.06
SMA200
13.09%
Avg Volume
331.59K
Price
23.43
IPO
Jul 28, 2016
Option/Short
Yes / Yes
Trades
Volume
187,087
Change
-2.21%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Upgrade Piper Sandler Neutral → Overweight $35
Nov-04-25Upgrade BTIG Research Neutral → Buy $28
Oct-03-25Initiated Lake Street Buy $23.50
May-06-25Downgrade Piper Sandler Overweight → Neutral $14
Feb-19-25Downgrade B. Riley Securities Buy → Neutral $23 → $18
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Mar-09-26 12:45PM
08:00AM
Feb-26-26 09:55AM
Feb-24-26 06:52AM
Feb-23-26 09:40AM
12:45PM Loading…
Feb-20-26 12:45PM
Feb-19-26 09:35AM
09:30AM
Feb-18-26 08:30AM
06:15AM
04:59AM
12:00AM
Feb-17-26 09:38PM
05:25PM
04:33PM
04:05PM Loading…
04:05PM
04:04PM
Feb-03-26 04:05PM
Jan-05-26 12:51PM
Dec-16-25 09:40AM
Nov-28-25 12:00PM
Nov-27-25 09:40AM
Nov-20-25 04:31AM
Nov-19-25 10:00AM
09:27AM
05:01AM
Nov-18-25 04:05PM
Nov-13-25 12:00PM
Nov-11-25 06:27AM
Nov-05-25 09:40AM
12:04AM Loading…
Nov-04-25 12:04AM
Nov-03-25 05:50PM
04:48PM
04:05PM
Oct-31-25 09:31AM
Oct-30-25 05:40PM
Oct-29-25 05:55PM
Oct-28-25 04:05PM
Oct-20-25 04:05PM
Sep-24-25 09:40AM
Sep-08-25 04:59PM
04:34PM
Aug-22-25 09:40AM
Aug-06-25 09:40AM
09:35AM
09:30AM
Aug-05-25 03:05AM
Aug-04-25 05:35PM
04:35PM
04:05PM
Jul-30-25 05:15PM
Jul-21-25 04:05PM
Jul-14-25 07:23AM
Jun-03-25 08:00AM
May-20-25 04:05PM
May-06-25 12:09PM
03:08AM
May-05-25 05:30PM
04:27PM
04:05PM
May-02-25 09:33AM
Apr-30-25 05:50PM
Apr-21-25 04:05PM
Apr-07-25 12:58PM
Mar-05-25 04:05PM
Feb-19-25 11:23AM
02:06AM
Feb-18-25 07:20PM
06:17PM
04:05PM
02:52AM
Feb-05-25 04:05PM
Feb-04-25 08:00AM
Jan-13-25 08:00AM
Jan-01-25 09:40AM
Dec-16-24 03:34PM
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dodd Sheri LouiseChief Executive OfficerFeb 24 '26Sale28.9410,993318,144243,885Feb 26 04:57 PM
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERFeb 24 '26Sale28.947,701222,880134,819Feb 26 04:56 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 24 '26Sale28.946,246180,76482,581Feb 26 04:55 PM
Burns KristieOfficerFeb 25 '26Proposed Sale28.474,000113,880Feb 25 10:01 AM
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERFeb 23 '26Sale28.305,518156,144142,520Feb 24 05:33 PM
Dodd Sheri LouiseChief Executive OfficerFeb 23 '26Sale28.3015,240431,245254,878Feb 24 05:32 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 23 '26Sale28.304,439125,61288,827Feb 24 05:32 PM
Dodd Sheri LouiseOfficerFeb 24 '26Proposed Sale28.9410,993318,148Feb 24 05:05 PM
Birkemeyer Elaine M.OfficerFeb 24 '26Proposed Sale28.947,701222,875Feb 24 04:59 PM
Burns KristieOfficerFeb 24 '26Proposed Sale28.946,246180,765Feb 24 04:29 PM
Burns KristieOfficerFeb 23 '26Proposed Sale28.304,439125,610Feb 23 03:41 PM
Dodd Sheri LouiseOfficerFeb 23 '26Proposed Sale28.3015,240431,246Feb 23 03:41 PM
Birkemeyer Elaine M.OfficerFeb 23 '26Proposed Sale28.305,518156,143Feb 23 03:41 PM
Burns KristieSr. VP Mktg & Clinical AffairsJan 02 '26Sale28.855,139148,26072,401Jan 06 04:53 PM
Burns KristieOfficerJan 02 '26Proposed Sale28.855,139148,260Jan 02 10:35 AM
Dodd Sheri LouiseChief Executive OfficerAug 08 '25Sale12.367,76295,907173,479Aug 12 06:03 PM
Dodd Sheri LouiseOfficerAug 08 '25Proposed Sale12.367,76295,906Aug 08 03:40 PM
Birkemeyer Elaine M.Chief Financial OfficerMay 12 '25Sale9.942,92129,03799,111May 14 05:26 PM
Birkemeyer Elaine M.OfficerMay 12 '25Proposed Sale9.942,92129,037May 12 05:25 PM
Dodd Sheri LouiseChief Executive OfficerMay 08 '25Sale9.833,14930,955181,241May 12 04:34 PM
BURKE WILLIAM WDirectorMay 08 '25Sale9.673,30031,91148,520May 09 04:28 PM
Dodd Sheri LouiseDirectorMay 08 '25Proposed Sale9.833,14930,955May 08 07:17 PM
BURKE WILLIAM WDirectorMay 08 '25Proposed Sale9.673,30031,911May 08 04:46 PM